DE69331992D1 - Verfahren zur hochaufreinigung von menschlichem serumalbumin - Google Patents

Verfahren zur hochaufreinigung von menschlichem serumalbumin

Info

Publication number
DE69331992D1
DE69331992D1 DE69331992T DE69331992T DE69331992D1 DE 69331992 D1 DE69331992 D1 DE 69331992D1 DE 69331992 T DE69331992 T DE 69331992T DE 69331992 T DE69331992 T DE 69331992T DE 69331992 D1 DE69331992 D1 DE 69331992D1
Authority
DE
Germany
Prior art keywords
human serum
high purification
serum albumine
albumine
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69331992T
Other languages
English (en)
Other versions
DE69331992T2 (de
Inventor
Naoto Fuluhata
Akinori Sumi
Takao Ohmura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of DE69331992D1 publication Critical patent/DE69331992D1/de
Publication of DE69331992T2 publication Critical patent/DE69331992T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69331992T 1992-07-31 1993-07-26 Verfahren zur hochaufreinigung von menschlichem serumalbumin Expired - Fee Related DE69331992T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20563792A JP3360315B2 (ja) 1992-07-31 1992-07-31 ヒト血清アルブミンの高度精製方法
PCT/JP1993/001048 WO1994003626A1 (en) 1992-07-31 1993-07-26 Method of highly purifying human serum albumin

Publications (2)

Publication Number Publication Date
DE69331992D1 true DE69331992D1 (de) 2002-07-11
DE69331992T2 DE69331992T2 (de) 2003-01-09

Family

ID=16510194

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69331992T Expired - Fee Related DE69331992T2 (de) 1992-07-31 1993-07-26 Verfahren zur hochaufreinigung von menschlichem serumalbumin

Country Status (8)

Country Link
US (1) US5656729A (de)
EP (1) EP0656419B1 (de)
JP (1) JP3360315B2 (de)
CA (1) CA2141439C (de)
DE (1) DE69331992T2 (de)
DK (1) DK0656419T3 (de)
ES (1) ES2177545T3 (de)
WO (1) WO1994003626A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
WO1997031947A1 (en) * 1996-02-29 1997-09-04 Delta Biotechnology Limited High purity albumin production process
US5994507A (en) * 1997-12-31 1999-11-30 Amersham Pharmacia Biotech Ab Method for binding albumin and means to be used in the method
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7297544B2 (en) * 1998-10-02 2007-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
CA2752729A1 (en) 2009-02-20 2010-08-26 Ventria Bioscience Cell culture media containing combinations of proteins
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562902A (en) * 1978-11-07 1980-05-12 Toray Ind Inc Separation of endotoxin
JPS59225121A (ja) * 1983-06-03 1984-12-18 Ajinomoto Co Inc インタ−ロイキン２の精製濃縮法
JPS6317898A (ja) * 1986-07-11 1988-01-25 Kyowa Hakko Kogyo Co Ltd リンホトキシン類の精製法
IL88326A (en) * 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
US5169936A (en) * 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
JPH03284692A (ja) * 1990-03-30 1991-12-16 Snow Brand Milk Prod Co Ltd ペプチド類の回収方法
US5330901A (en) * 1991-04-26 1994-07-19 Research Corporation Technologies, Inc. Expression of human serum albumin in Pichia pastoris
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same

Also Published As

Publication number Publication date
WO1994003626A1 (en) 1994-02-17
DE69331992T2 (de) 2003-01-09
DK0656419T3 (da) 2002-09-30
EP0656419A4 (de) 1996-05-29
CA2141439A1 (en) 1994-02-17
JPH0646873A (ja) 1994-02-22
CA2141439C (en) 2003-09-30
US5656729A (en) 1997-08-12
EP0656419A1 (de) 1995-06-07
EP0656419B1 (de) 2002-06-05
ES2177545T3 (es) 2002-12-16
JP3360315B2 (ja) 2002-12-24

Similar Documents

Publication Publication Date Title
DE69331507D1 (de) Verfahren zur Reinigung von menschlichem, rekombinantem Serumalbumin
DE69532492D1 (de) Verfahren zur Reinigung von rekombinantem menschlichem Serumalbumin
DE69329461D1 (de) Verfahren zur extraktion und reinigung von hamoglobin
DE69331992T2 (de) Verfahren zur hochaufreinigung von menschlichem serumalbumin
DE69124638D1 (de) Verfahren zur Reinigung von Alkoxysilanen
DE69220113D1 (de) Verfahren zur Herstellung von menschlichem Serum Albumin
DE59303220D1 (de) Verfahren zur Herstellung von 1-Fluorcyclopropyl-methyl-keton
DE69314899T2 (de) Verfahren zur Herstellung von Polyaminoborazinen
DE69312604T2 (de) Verfahren zur Herstellung von Dipeptid-Körnchen
DE69315297D1 (de) Verfahren zur Herstellung von Omega-Alkenylchlorsilanen
DE69325079T3 (de) Verfahren zur Herstellung von Triorganochlorsilane
DE69303057D1 (de) Verfahren zur Herstellung von 3-Cyano-6-hydroxypyridin
DE59401489D1 (de) Verfahren zur Herstellung von 5-Cyanvaleriansäureestern
DE69431097T2 (de) Verfahren zur Herstellung von humanem Serumalbumin
DE69315317T2 (de) Verfahren zur Herstellung von beta-Cyanoalkylsilanen
DE59305081D1 (de) Verfahren zur herstellung von hexafluorchlorbutenen
DE59403834D1 (de) Verfahren zur Herstellung von m-Chloraromaten
DE69318765D1 (de) Verfahren zur Herstellung von Hydridoorganooxysilanen
DE69321661D1 (de) Verfahren zur Herstellung von Triorganomonohalogensilan
DE69304224D1 (de) Verfahren zur Herstellung von P-Aminophenolen
DE69409551D1 (de) Verfahren zur Herstellung von 2-Chloro-5-aminomethylpyridinen
DE69305279D1 (de) Verfahren zur Herstellung von Dimethyltetralin
DE69308193D1 (de) Verfahren zur Herstellung von Alpha-L-Aspartyl-L-Phenylalanin
DE69305275D1 (de) Verfahren zur Herstellung von Lithium-N-Methylaminobutyrat
DE59301861D1 (de) Verfahren zur Herstellung von 2-Aryl-ethan-sulfonsäuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee